DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence

@article{Mota2013DRD2DRD4HM,
  title={DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence},
  author={Nina Roth Mota and Diego Luiz Rovaris and Guilherme Pinto Bertuzzi and Ver{\^o}nica Contini and Eduardo Schneider Vitola and Eugenio Horacio Grevet and Thibeaux Roman and Sidia Maria Callegari-jacques and Mara H Hutz and C H D Bau},
  journal={Molecular Psychiatry},
  year={2013},
  volume={18},
  pages={401-402}
}
RHP is a consultant to CogState. JHK has been a consultant to Aisling Capital LLC; AstraZeneca Pharmaceuticals; Brintnall & Nicolini; Easton Associates, LLC; Gilead Sciences; GlaxoSmithKline; Ortho-McNeil-Janssen Pharmaceuticals; Lundbeck Research USA; Merz Pharmaceuticals GmbH; MK Medical Communications; Pfizer; F Hoffmann--La Roche; SK Holdings; Takeda Pharmaceutical; Teva Pharmaceutical Industries and Transcept Pharmaceuticals. SH, SMS and AN declare no conflict of interest. 
BETA
1
Twitter Mention